In vitro effects of hypoxia-inducible factor 1α on the biological aracteristics of the siHa uterine cervix cancer cell line

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 898-904

  Tang, Binzhi ^a   Qu, Yi ^a   Zhao, Fengyan ^a   Mao, Meng ^a   Tang, Jun ^a   Li, Xihong ^a   Donna, Ferriero ^b   Dezhi, Mu ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Hypoxia inducible factor 1 ; Migration; Proliferation; Uterine cervix cancer cell SiHa

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; ANTIMUTAGENIC AGENT; COBALT; COBALT CHLORIDE; CXCR4 PROTEIN, HUMAN; FAM162A PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NICK END LABELING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; CELL ADHESION; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR;

ANTIMUTAGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COBALT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69449101867     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a14f9a     Document Type: Article

References (28)

1. Fukuda R, Zhang H, Kim JW, et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell. 2007;129:111-122.
2. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006;59:15-26.
3. Kilic M, Kasperczyk H, Fulda S, et al. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene. 2007;26:2027-2038.
4. Esteban MA, Tran MG, Harten SK, et al. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 2006;66:3567Y3575.
5. Li J, Shi M, Cao Y, et al. Knockdown of hypoxia-inducible factor-1> in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. Biochem Biophys Res Commun. 2006;342:1341-1351.
6. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A. 1998;95:7987-7992.
7. Stiehl DP, Jelkmann W, Wenger RH, et al. Normoxic induction of the hypoxia-inducible factor-1> by insulin and interleukin-1A involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 2002;512: 157-162.
8. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002;64:993-998.
9. Bardos JI, Ashcrof M. Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta. 2005;1755:107-120.
10. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia inducible factor 1 alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830-5835.
11. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001;11:293-299.
12. Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108-113.
13. Kim JY, Ahm HJ, Ryu JH, et al. BH3-only protein Noxa is a mediator of hypoxia cell death induced by hypoxia-inducible factor 1 α. J Exp Med. 2004;199:113-124.
14. Lee MJ, Kim JY, Suk K, et al. Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol. 2004;24:3918-3927.
15. Chen D, Li M, Luo J, et al. Direct interactions between HIF-1 and Mdm2 modulate p53 function. J Biol Chem. 2003;278:13595-13598.
16. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-732.
17. Birner P, Schindl M, Obermair A, et al. Overexpression of hypoxiainducible factor 1 > is a maker for an unfavorable prognosis in early stage invasive cervical cancer. Cancer Res. 2000;60:4693-4696.
18. Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia-inducible factor 1 α indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res. 2003;9:2234-2240.
19. Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1 α expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:169-174.
20. Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1 α expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:169Y174. 20. Chen J, Zhao S, Nakada K, et al. Dominant-negative hypoxia-inducible factor-1 α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol. 2003;162: 1283-1291.
21. Ji Z, Yang G, Shahzidi S, et al. Induction of hypoxia-inducible factor-1α overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett. 2006;244:182-189.
22. Roskoski R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol. 2007;62:179-213.
23. Zheng H, Fu G, Dai T, et al. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1α/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2007;50:274-280.
24. Zhang P, Wang Y, Hui Y, et al. Inhibition of VEGF expression by targeting HIF-1 α with small interference RNA in human RPE cells. Ophthalmologica. 2007;221:411-417.
25. Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res. 2006;4:601-605.
26. Jensen RL, Ragel BT, Whang K, et al. Inhibition of hypoxia inducible factor-1 > (HIF-1>) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol. 2006;78:233-247.
27. Stoeltzing O, McCarty MF, Wey JS, et al. Role of hypoxia-inducible factor 1 > in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst. 2004;96:946-956.
28. Brown LM, Cowen RL, Debray C, . Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol Pharmacol. 2006;69:411-418.